third-generation egfr inhibitors in nsclc
Published 9 years ago • 1.2K plays • Length 6:14Download video MP4
Download video MP3
Similar videos
-
8:30
third-generation egfr inhibitors in nsclc
-
4:48
third-generation egfr inhibitors in nsclc
-
7:31
newer egfr inhibitors in nsclc
-
4:28
overcoming resistance to egfr inhibitors in nsclc
-
2:36
second- and third-generation tkis in egfr-mutated nsclc
-
3:28
emerging egfr inhibitors in nsclc
-
1:48
acquired resistance to third-generation egfr tkis in nsclc
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
0:53
ramalingam compares third generation egfr tki osimertinib to older agents in nsclc
-
3:41
egfr inhibitors as adjuvant therapy in nsclc
-
7:51
nsclc: egfr inhibition and resistance mechanisms
-
3:28
should third generation egfr inhibitors be used before or after progression?
-
3:45
azd9291 and rociletinib in t790m-mutant nsclc
-
3:35
novel egfr inhibitor combinations for nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
6:03
promising egfr inhibitors in development for nsclc
-
4:59
egfr therapy in nsclc